Watermark
  Back to Search Results

BGB-900-103

Completed

A Phase 1b Study to Assess Sitravatinib in Combination With Tislelizumab in Participants With Advanced Solid Tumors

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-900-103

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT03666143

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20181404

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan